A novel NKX2.5 loss-of-function mutation responsible for familial atrial fibrillation.

作者: JIAN LI , WEI-DONG LIU , ZHONG-LIANG YANG , YI-QING YANG

DOI: 10.3892/IJMM.2012.1068

关键词:

摘要: Abstract Atrial fibrillation (AF) represents the most common form of sustained cardiac arrhythmia and accounts for substantial morbidity mortality. Increasing evidence demonstrates that abnormal cardiovascular development is involved in pathogenesis AF. In this study, coding exons splice sites NKX2.5 gene, which encodes a homeodomain-containing transcription factor pivotal normal morphogenesis, were sequenced 110 unrelated index patients with familial The available relatives mutation carrier 200 ethnically-matched healthy individuals serving as controls subsequently genotyped. disease-causing potential identified variation was predicted by MutationTaster. functional characteristics mutant protein analyzed using dual-luciferase reporter assay system. As result, novel heterozygous mutation, p.F145S, family AF transmitted an autosomal dominant trait, co-segregated complete penetrance. detected substitution, altered amino acid completely conserved evolutionarily across species, absent 400 control chromosomes automatically to be causative. Functional analysis demonstrated associated significantly decreased transcriptional activity compared its wild-type counterpart. To best our knowledge, first report on association loss-of-function increased susceptibility findings present study provide insights into molecular mechanism underlying AF, suggesting implications early prophylaxis allele-specific therapy

参考文章(85)
S. Pabst, B. Wollnik, E. Rohmann, Y. Hintz, K. Glänzer, H. Vetter, G. Nickenig, Christian Grohé, A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomaldominant inherited congenital heart disease Clinical Research in Cardiology. ,vol. 97, pp. 39- 42 ,(2008) , 10.1007/S00392-007-0574-0
Xing-Yuan Liu, A novel GATA6 mutation associated with congenital ventricular septal defect. International Journal of Molecular Medicine. ,vol. 29, pp. 1065- 1071 ,(2012) , 10.3892/IJMM.2012.930
Alicia Lundby, Lasse Steen Ravn, Jesper Hastrup Svendsen, Stig Haunsø, Søren-Peter Olesen, Nicole Schmitt, KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cellular Physiology and Biochemistry. ,vol. 21, pp. 047- 054 ,(2008) , 10.1159/000113746
Benoit G. Bruneau, The developmental genetics of congenital heart disease Nature. ,vol. 451, pp. 943- 948 ,(2008) , 10.1038/NATURE06801
Y. Zhang, N. Rath, S. Hannenhalli, Z. Wang, T. Cappola, S. Kimura, E. Atochina-Vasserman, M. M. Lu, M. F. Beers, E. E. Morrisey, GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo. Development. ,vol. 134, pp. 189- 198 ,(2007) , 10.1242/DEV.02720
Jean-Jacques Schott, D Woodrow Benson, Craig T Basson, William Pease, G Michael Silberbach, Jeffrey P Moak, Barry J Maron, Christine E Seidman, JG Seidman, Congenital Heart Disease Caused by Mutations in the Transcription Factor NKX2-5 Science. ,vol. 281, pp. 108- 111 ,(1998) , 10.1126/SCIENCE.281.5373.108
Yi-Qing Yang, A novel GATA4 mutation responsible for congenital ventricular septal defects. International Journal of Molecular Medicine. ,vol. 28, pp. 557- 564 ,(2011) , 10.3892/IJMM.2011.715
Leif-Hendrik Boldt, Maximilian G. Posch, Andreas Perrot, Michael Polotzki, Sascha Rolf, Abdul S. Parwani, Martin Huemer, Alexander Wutzler, Cemil Özcelik, Wilhelm Haverkamp, Mutational analysis of the PITX2 and NKX2-5 genes in patients with idiopathic atrial fibrillation. International Journal of Cardiology. ,vol. 145, pp. 316- 317 ,(2010) , 10.1016/J.IJCARD.2009.11.023
Yiqing Yang, Jun Li, Xiaoping Lin, Yanzong Yang, Kui Hong, Lei Wang, Jinqiu Liu, Li Li, Dinghong Yan, Dandan Liang, Junjie Xiao, Hongmei Jin, Jie Wu, Yangyang Zhang, Yi-Han Chen, Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. Journal of Human Genetics. ,vol. 54, pp. 277- 283 ,(2009) , 10.1038/JHG.2009.26
Hiroshi Akazawa, Issei Komuro, Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases Pharmacology & Therapeutics. ,vol. 107, pp. 252- 268 ,(2005) , 10.1016/J.PHARMTHERA.2005.03.005